These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36388829)

  • 1. Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study.
    Jin J; Zhu J; Zhu Z; Kim WY; O'Rourke J; Lin Z; Chen M
    Ann Transl Med; 2022 Oct; 10(20):1137. PubMed ID: 36388829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB.
    Wang J; Shah BK; Zhao J; Xiong J; Wang C; Xie S
    BMC Infect Dis; 2023 May; 23(1):351. PubMed ID: 37231342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection.
    Zheng Z; Shao Z; Lu L; Tang S; Shi K; Gong F; Liu J
    BMC Infect Dis; 2023 Oct; 23(1):709. PubMed ID: 37864200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study.
    Bao XL; Tao T; Tang N; Wang YZ; Liao XQ; Huang LL; Ji JJ; Chen X
    Ann Palliat Med; 2022 Sep; 11(9):2939-2951. PubMed ID: 36217623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of Colistin-Carbapenem versus Colistin-Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study.
    Wang SH; Yang KY; Sheu CC; Chen WC; Chan MC; Feng JY; Chen CM; Wu BR; Zheng ZR; Chou YC; Peng CK; On Behalf Of The T-Care Taiwan Critical Care Infection Group
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572663
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli.
    Hao M; Yang Y; Guo Y; Wu S; Hu F; Qin X
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study.
    Feng JY; Huang JR; Lee CC; Tseng YH; Pan SW; Chen YM; Yang KY
    Ann Intensive Care; 2023 Jan; 13(1):1. PubMed ID: 36609725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria.
    Xu HC; Cui Y; Wang XY; Wu HB; Li W; Wang D; Lin N; Lin L; Zhang YH
    World J Clin Cases; 2024 May; 12(13):2173-2181. PubMed ID: 38808336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study.
    Feng JY; Peng CK; Sheu CC; Lin YC; Chan MC; Wang SH; Chen CM; Shen YC; Zheng ZR; Lin YT; Yang KY;
    Clin Microbiol Infect; 2021 Oct; 27(10):1465-1473. PubMed ID: 33540113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study.
    Feng JY; Lee YT; Pan SW; Yang KY; Chen YM; Yen DH; Li SY; Wang FD
    Antimicrob Resist Infect Control; 2021 Jul; 10(1):111. PubMed ID: 34330333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases.
    Wu Y; Jiang S; Li D; Wu Y; Li Q; Wang X; Liu B; Bao H; Wu D; Hu X
    Infect Dis Ther; 2024 Jan; 13(1):141-154. PubMed ID: 38212555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan.
    Babar ZU; Dodani SK; Nasim A
    Int J Infect Dis; 2021 May; 106():171-175. PubMed ID: 33705852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Analysis of Colistin Sulfate in the Treatment of Hematonosis Infected by Multidrug-Resistant Gram-Negative Bacteria].
    Wu YB; Jiang SS; Wu YX; Li DY; Li Q; Wang X; Liu B; Bao HY; Hu XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1878-1884. PubMed ID: 38071076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of colistin sulfate in the treatment of infections caused by carbapenem-resistant organisms: a multicenter retrospective cohort study.
    Peng D; Zhang F; Chen Y; Zhao C; Niu J; Yang J; Li Z; Chen C; Qiu S; Zhang H; Qin B; Fang X; Guo S; Liu Y; Shao H
    J Thorac Dis; 2023 Apr; 15(4):1794-1804. PubMed ID: 37197520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
    Nazer LH; Rihani S; Hawari FI; Le J
    Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection.
    Maan L; Anand N; Yadav G; Mishra M; Gupta MK
    Cureus; 2023 Nov; 15(11):e49314. PubMed ID: 38143689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis.
    Karageorgos SA; Bassiri H; Siakallis G; Miligkos M; Tsioutis C
    J Antimicrob Chemother; 2019 Sep; 74(9):2497-2506. PubMed ID: 31049586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections.
    Lu Q; Zhu HH; Li GH; Qi TT; Ye LJ; Teng XQ; Qu Q; He GF; Qu J
    Front Med (Lausanne); 2021; 8():620885. PubMed ID: 33634151
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.